BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20237327)

  • 1. CCN notch signaling in vascular smooth muscle cells: good or bad?
    Abe J; Yan C
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):667-8. PubMed ID: 20237327
    [No Abstract]   [Full Text] [Related]  

  • 2. CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration.
    Shimoyama T; Hiraoka S; Takemoto M; Koshizaka M; Tokuyama H; Tokuyama T; Watanabe A; Fujimoto M; Kawamura H; Sato S; Tsurutani Y; Saito Y; Perbal B; Koseki H; Yokote K
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):675-82. PubMed ID: 20139355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCN1 (CYR61) and CCN3 (NOV) signaling drives human trophoblast cells into senescence and stimulates migration properties.
    Kipkeew F; Kirsch M; Klein D; Wuelling M; Winterhager E; Gellhaus A
    Cell Adh Migr; 2016 Mar; 10(1-2):163-78. PubMed ID: 26744771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia by CREB-mediated p21 induction: An insight from a plant polyphenol.
    Sun L; Zhao R; Zhang L; Zhang W; He G; Yang S; Song J; Du G
    Biochem Pharmacol; 2016 Mar; 103():40-52. PubMed ID: 26807478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
    Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
    Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
    Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
    Ashino T; Yamamoto M; Yoshida T; Numazawa S
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Jagged-1 inhibits neointima formation by attenuating Notch-Herp2 signaling.
    Caolo V; Schulten HM; Zhuang ZW; Murakami M; Wagenaar A; Verbruggen S; Molin DG; Post MJ
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1059-65. PubMed ID: 21330605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking potassium channels: a new principle for treating restenosis?
    Olschewski A
    Cardiovasc Res; 2011 Feb; 89(2):255-7. PubMed ID: 21156820
    [No Abstract]   [Full Text] [Related]  

  • 10. Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo.
    Schwaiberger AV; Heiss EH; Cabaravdic M; Oberan T; Zaujec J; Schachner D; Uhrin P; Atanasov AG; Breuss JM; Binder BR; Dirsch VM
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2475-81. PubMed ID: 20847306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch signalling in smooth muscle cells during development and disease.
    Fouillade C; Monet-Leprêtre M; Baron-Menguy C; Joutel A
    Cardiovasc Res; 2012 Jul; 95(2):138-46. PubMed ID: 22266753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BubR1 insufficiency inhibits neointimal hyperplasia through impaired vascular smooth muscle cell proliferation in mice.
    Kyuragi R; Matsumoto T; Harada Y; Saito S; Onimaru M; Nakatsu Y; Tsuzuki T; Nomura M; Yonemitsu Y; Maehara Y
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):341-7. PubMed ID: 25524773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27(Kip1) and p21(Cip1)-independent proliferative inhibition of vascular smooth muscle cells cultured in type-I collagen matrix honeycombs.
    Uchida M; Suzuki S; Suzuki T; Ishii I
    Microvasc Res; 2016 Jan; 103():36-40. PubMed ID: 26522285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble JAGGED1 inhibits pulmonary hypertension by attenuating notch signaling.
    Xiao Y; Gong D; Wang W
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2733-9. PubMed ID: 24072692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of alcohol and its metabolite acetaldehyde on vascular smooth muscle cell Notch signaling and growth.
    Hatch E; Morrow D; Liu W; Cahill PA; Redmond EM
    Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H131-H137. PubMed ID: 29212792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apamin inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through suppressions of activated Akt and Erk signaling pathway.
    Kim JY; Kim KH; Lee WR; An HJ; Lee SJ; Han SM; Lee KG; Park YY; Kim KS; Lee YS; Park KK
    Vascul Pharmacol; 2015 Jul; 70():8-14. PubMed ID: 25737404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
    Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells.
    Lee KP; Sudjarwo GW; Jung SH; Lee D; Lee DY; Lee GB; Baek S; Kim DY; Lee HM; Kim B; Kwon SC; Won KJ
    Atherosclerosis; 2015 Jun; 240(2):367-73. PubMed ID: 25875388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.